VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PLURPluri Inc.
$2.03$18M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPLURBalance Sheet

Pluri Inc. (PLUR) Balance Sheet

24Y historyFree accessUpdated daily

The company's financial position is increasingly fragile, with total debt reaching $33.6M against a total asset base of only $26.1M, resulting in a concerning equity deficit of $18.6M.

PLUR Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMJun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02
Total Current Assets10.46M22.09M31.11M41.41M57.75M67.37M48.46M26.37M32.04M29.02M35.6M56.87M61.99M55.09M38.19M43.3M3.6M2.94M2.11M6.05M2.54M2.1M741.11K517.62K961
Cash & Short-Term Investments9.55M20.61M29.98M40.17M55.02M64.95M46.34M23.7M29.9M26.11M32.21M52.04M53.91M53.9M37.81M42.83M1.58M2.34M1.51M5.41M2.37M1.89M668.87K507.34K961
Cash Only3.65M5.89M6.78M5.36M9.77M31.24M8.82M4.11M8.82M4.71M6.22M22.63M4.49M9.01M30.79M42.83M1.58M2.34M323K1.65M2.37M1.89M668.87K507.34K961
Short-Term Investments5.9M14.72M23.2M34.81M45.24M33.71M37.51M19.6M21.08M21.4M25.98M29.42M49.41M44.89M7.02M0001.19M3.76M00000
Accounts Receivable99K722K638K527K1.32M1.49M1.61M1.42M847K1.17M2.48M2.51M2.26M273K338K154K1.07M496K249K582.43K101.07K147.78K15.33K10.28K0
Days Sales Outstanding108.59197.25714.33670.232.06K-25.55K9.6K6.18K-318.082.42K2.18K146.75172.3-33.42---------
Inventory0000000692K00004.91M00041K00000000
Days Inventory Outstanding-------126.29K----163.06K------------
Other Current Assets816K525K262K269K1.01M598K67K21K00607K04.96M32.36M00000000000
Total Non-Current Assets15.59M16.59M8.42M9.39M10.32M26.17M17.07M4.94M6.92M8.52M10.35M11.29M12.04M13.23M9.23M2.72M2.02M1.53M1.48M673.48K887.18K521.52K636.09K476.98K15.57K
Property, Plant & Equipment8.04M8.72M7.25M8.32M9.01M2.23M3.77M3.84M5.68M7.28M9.22M10.17M10.82M11.87M5.02M2.09M1.55M1.2M1.15M467.61K254.69K249.09K226.45K123.25K0
Fixed Asset Turnover0.13x0.15x0.04x0.03x0.03x-0.01x0.01x0.01x-0.31x0.04x0.04x0.06x0.14x-0.81x---------
Goodwill3.14M3.14M00000000000000000000000
Intangible Assets2.66M2.79M000000000000000000000333.89K0
Long-Term Investments1.89M0000012.65M398K383K403K363K0000631K462K325K0000000
Other Non-Current Assets815K1.94M1.17M1.07M1.31M23.94M643K703K863K838K766K1.11M1.21M1.36M4.21M000328K205.87K632.49K272.43K409.64K19.84K15.57K
Total Assets26.06M38.68M39.53M50.8M68.06M93.54M65.53M31.31M38.96M37.53M45.94M68.16M74.02M68.32M47.42M46.02M5.62M4.46M3.58M6.73M3.42M2.62M1.38M994.59K16.54K
Asset Turnover0.03x0.03x0.01x0.01x0.00x-0.00x0.00x0.00x-0.06x0.01x0.01x0.01x0.02x-0.04x---------
Asset Growth %-38.33%-2.14%-22.19%-25.37%-27.23%42.74%109.3%-19.64%3.8%-18.3%-32.59%-7.93%8.35%44.07%3.05%718.5%25.97%24.53%-46.72%96.42%30.71%90.24%38.47%5914.72%-
Total Current Liabilities32.01M32.33M4.45M5.62M6.83M11.52M7.99M8.16M8.55M5.41M5.78M6.18M7.4M5.92M5.52M2.02M1.28M840K1.07M732.86K734.38K450.99K391.61K256K91.94K
Accounts Payable743K866K964K1.81M1.78M2.53M1.97M2.28M3.26M1.97M2.71M3.27M3.46M2.84M1.37M1.18M791K759K918K364.66K351.76K185.07K112.88K132.56K10.29K
Days Payables Outstanding365.42463.4887.97K73.49K618.73672.99457.53416.28K595.13K329.629.87K91.76K114.97K51.78K23.78K---------626.22
Short-Term Debt28.03M27.29M00001.02M0000000000000218.75K18.75K100.02K123.44K0
Deferred Revenue (Current)717K341K124K151K112K40K126K0640K00472K626K772K792K-60K00000175.81K0-256K0
Other Current Liabilities3.01M859K702K873K1.51M1.2M3.02M0946K687K560K390K1.29M413K321K513K123K00237.86K071.35K105.12K081.64K
Current Ratio0.33x0.68x6.98x7.37x8.46x5.85x6.07x3.23x3.75x5.36x6.16x9.20x8.38x9.30x6.92x21.46x2.81x3.49x1.97x8.26x3.46x4.65x1.89x2.02x0.01x
Quick Ratio0.33x0.68x6.98x7.37x8.46x5.85x6.07x3.15x3.75x5.36x6.16x9.20x7.72x9.30x6.92x21.46x2.78x3.49x1.97x8.26x3.46x4.65x1.89x2.02x0.01x
Cash Conversion Cycle-256.83-------280.39K----50.26K------------
Total Non-Current Liabilities7.05M7.22M29.66M29.88M29.05M24.87M1.44M1.33M1.91M1.87M2.01M3.83M4.5M4.93M4.16M576K360K229K183K96.89K3.33M365.93K628.58K248.18K0
Long-Term Debt0024.03M23.53M21.68M23.85M0000000000023K36K02.07M0000
Capital Lease Obligations23.88M6.1M5.03M5.75M6.5M100K565K000000000000000000
Deferred Tax Liabilities1.61M415K00000000000000000000000
Other Non-Current Liabilities1.06M703K605K598K867K920K879K1.33M1.91M1.87M2.01M1.36M1.66M1.7M651K576K360K206K147K96.89K1.27M365.93K628.58K248.18K0
Total Liabilities39.06M39.55M34.11M35.5M35.88M36.39M9.43M9.49M10.45M7.28M7.79M10.01M11.9M10.85M9.68M2.59M1.64M1.07M1.25M829.74K4.07M816.91K1.02M504.18K91.94K
Total Debt33.63M34.05M29.61M29.91M28.8M24.58M1.58M000000010K60K20K23K36K02.28M18.75K100.02K123.44K0
Net Debt29.98M28.16M22.83M24.55M19.03M-6.66M-7.24M-4.11M-8.82M-4.71M-6.22M-22.63M-4.49M-9.01M-30.78M-42.77M-1.56M-2.32M-287K-1.65M-89.65K-1.87M-568.84K-383.9K-961
Debt / Equity-2.59x-5.47x1.95x0.89x0.43x0.03x-------0.00x0.00x0.01x0.01x0.02x--0.01x0.28x0.25x-
Debt / EBITDA-1.31x------------------------
Net Debt / EBITDA-1.17x------------------------
Interest Coverage-59.09x-25.64x-23.65x-33.27x-45.64x-638.29x-147.73x-1217.48x-27.88x--233.19x-682.89x-773.61x-728.48x-1252.58x-833.46x-239.94x-834.88x--325.01x-----21.58x
Total Equity-13M-865K5.42M15.3M32.19M57.15M56.1M21.82M28.51M30.25M38.16M58.14M62.12M57.47M37.74M43.42M3.98M3.39M2.33M5.9M-644.23K1.8M357.01K490.42K-75.4K
Equity Growth %-11986.61%-115.97%-64.61%-52.46%-43.68%1.87%157.1%-23.45%-5.77%-20.72%-34.38%-6.41%8.1%52.26%-13.08%990.73%17.3%45.73%-60.51%1015.38%-135.73%405.06%-27.2%750.39%-
Book Value per Share-1.29-0.141.033.348.0016.2624.6614.1521.5527.6838.3766.1878.2582.8668.57111.3418.7325.6129.01327.09-169.00174.3521.3729.36-4.51
Total Shareholders' Equity-18.6M-6.84M96K13.36M30.04M57.15M56.1M21.82M28.51M30.25M38.16M58.14M62.12M57.47M37.74M43.42M3.98M3.39M2.33M5.9M-644.23K1.8M357.01K490.42K-75.4K
Common Stock00000001K1K1K1K1K000005.46M09.91K63663626821825
Retained Earnings-461M-443.06M-420.47M-399.58M-371.26M-330.02M-280.16M-251M-215.7M-189.57M-161.76M-138.51M-113.83M-86.9M-65.75M-50.95M-40.1M-32.65M-26.02M-15.52M-7.09M-4.65M-2.55M-540.9K-77.9K
Treasury Stock0000000000000000000000000
Accumulated OCI00000000-11.21M2M1.48M2.14M2.96M259K-130K-890K-620K-416K-248K337.65K-98.72K-56.18K-29.21K933.46K0
Minority Interest5.6M5.98M5.32M1.95M2.15M00000000000000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent liquidity and solvency risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Deteriorating Solvency and Equity Erosion

As reported in recent financial filings, Pluri's equity position has collapsed into a deficit of $18.6M by 2026Q3, a stark reversal from the positive equity levels observed in 2024, signaling a rapid erosion of shareholder value driven by persistent, large-scale operational losses.

The consistent decline in total equity suggests that the company is consuming its capital base to fund ongoing R&D and operational overhead. This trajectory indicates that the current business model is not generating sufficient value to offset the costs of maintaining its specialized manufacturing infrastructure.

Rising Leverage Amidst Capital Scarcity

Based on the latest quarterly data, Pluri's total debt has climbed to $33.6M, representing a significant portion of the company's $26.1M asset base, which suggests that management is increasingly reliant on debt financing to sustain operations in the absence of meaningful commercial revenue.

The high debt-to-asset ratio implies that the company's financial flexibility is severely constrained, leaving little room for error in its clinical or commercial execution. Investors should monitor whether these debt obligations carry restrictive covenants that could further limit the company's strategic options during this critical transition phase.

Critical Liquidity Buffer Rapidly Depleting

According to recent SEC filings, Pluri's current ratio has plummeted to 0.33 as of 2026Q3, down from 7.12 in 2024Q2, indicating that the company's ability to meet short-term obligations is severely compromised and that its cash runway is nearing a critical exhaustion point.

The sharp contraction in liquidity metrics highlights an urgent need for external capital, as the current cash balance of $3.6M is insufficient to cover the company's historical quarterly burn rate. This liquidity profile suggests that the firm may be forced into highly dilutive financing or unfavorable debt terms.

Hidden Risks in Asset Valuation

As disclosed in financial statements, the presence of $3.1M in goodwill alongside $8.0M in net PPE warrants caution, as these assets may be subject to impairment if the company's pivot to CDMO services fails to generate the anticipated commercial traction or clinical validation.

The reliance on specialized manufacturing equipment creates a risk of asset obsolescence should the company's proprietary 3D bioreactor technology fail to gain market adoption. Analysts should consider that the book value of these assets may not reflect their true economic utility in a liquidation or restructuring scenario.

PLUR — Frequently Asked Questions

Quick answers to the most common questions about buying PLUR stock.

What are the total assets of Pluri Inc. (PLUR)?

As of 2025, Pluri Inc. (PLUR) had total assets of $38.7M including $22.1M in current assets.

How much debt does Pluri Inc. (PLUR) have?

Pluri Inc. (PLUR) carries total debt of $34.0M, offset by $20.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Pluri Inc.?

Pluri Inc. (PLUR) has total shareholders' equity (book value) of $-6.8M ($-0.14 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Pluri Inc.'s current ratio and liquidity?

Pluri Inc. (PLUR) reported a current ratio of 0.68x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.